跳至主要内容
临床试验/NCT05007067
NCT05007067终止不适用

A Retrospective Study Evaluating Clinical and Radiographic Early Outcomes of Total Hip Arthroplasty with DELTA Multihole TT Acetabular Cup.

Limacorporate S.p.a1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2022年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
7
试验地点
1
主要终点
Harris Hip Score (HHS)

研究概览

简要总结

This study is aimed to provide a clinical and radiographic evaluation of 50 suitable subjects who underwent a complex primary or a revision Total Hip Arthroplasties with DELTA Multihole TT acetabular cup in 2019 onwards.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects who underwent a Total Hip Arthroplasty with Delta Multihole TT acetabular cup, as per indications for use, in 2019 onwards
  • Age ≥ 18 years old
  • Subjects who have signed the written informed consent approved by the reference Ethics Committee (EC)
  • Subjects able to comply with the protocol and to perform all scheduled follow-up visits

排除标准

  • Male or female subjects who underwent a Total Hip Arthroplasty with Delta Multihole TT acetabular cup, but showed any of the contraindications reported in the Instruction for Use
  • Age < 18 years old
  • Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation including, but not limited to:
  • significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery.
  • neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device.
  • known metabolic disorders leading to progressive bone deterioration.
  • Hip replacement on the contralateral side performed within less than one year.
  • Female subjects who are pregnant, nursing or planning a pregnancy.

结局指标

主要结局

Harris Hip Score (HHS)

时间窗: Month 24

The percentage of subjects showing a Harris Hip Score (HHS) equal or greater than "Good" (i.e. equal or greater than 80 points) at 2 years after the surgery.

次要结局

  • ROM measurement(Pre-operative - Month 24)
  • Survival rate(Month 24)
  • VAS Pain(Pre-operative - Month 24)
  • Implant stability(Month 24)
  • Safety assessment(Intra-operative, Week 2, Week 6, Month 6, Month 12, Month 24)

研究者

发起方
Limacorporate S.p.a
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验